Negative Feedback on the Effects of Stem Cell Factor on Hematopoiesis is Partly Mediated Through Neutral Endopeptidase Activity on Substance P: a Combined Functional and Proteomic Study
Overview
Authors
Affiliations
Hematopoietic regulation is a complex but dynamic process regulated by intercellular and intracellular interactions within the bone marrow (BM) microenvironment. Through neurokinin-1 (NK-1) and NK-2 receptors, peptides (eg, substance P [SP]) encoded by the preprotachykinin-I gene mediate distinct hematopoietic effects. Cytokines, associated with hematopoietic stimulation, and SP regulate the expression of each other in BM mesenchymal and immune cells. Neutral endopeptidase (NEP) uses SP as a substrate to produce SP(1-4), which inhibits the proliferation of matured myeloid progenitor. This study determines whether the degradation of SP to SP(1-4) by endogenous NEP in BM stroma could be a feedback on hematopoietic stimulation by stem cell factor (SCF). SP(1-4) induced the production of transforming growth factor (TGF)-beta and tumor necrosis factor-alpha in BM stroma. TGF-beta production accounted for part of the inhibitory effects by SP(1-4) on the proliferation of early (granulocyte-macrophage colony-forming units) and late (long-term culture-initiating cells) hematopoietic progenitors. Enzyme-linked immunosorbent assays and/or protein-chip arrays indicated a timeline change of SP to SP(1-4) in BM stroma stimulated with SCF, which correlated with increase in NEP messenger RNA. Since SP and its fragment, SP(1-4), interact with the same receptor to mediate opposing hematopoietic effects, 2 interactive studies were done to understand the dual responses of NK-1: (1) a 3-dimensional molecular model of NK-1 and SP and (2) screening of a random dodecapeptide library for SP(1-4) interacting sites. The effects of SP(1-4) on hematopoietic progenitors and the timeline change of SP to SP(1-4), together with the 3-dimensional model, provide a partial explanation for the feedback on the stimulatory effects of SCF and SP on hematopoiesis.
Greco S, Ayer S, Guiro K, Sinha G, Donnelly R, El-Far M Aging (Albany NY). 2021; 13(21):23981-24016.
PMID: 34762598 PMC: 8610119. DOI: 10.18632/aging.203689.
Watamura N, Kakiya N, Nilsson P, Tsubuki S, Kamano N, Takahashi M Mol Psychiatry. 2021; 27(3):1816-1828.
PMID: 34737456 PMC: 9095489. DOI: 10.1038/s41380-021-01368-8.
Gergues M, Nagula V, Bliss S, Eljarrah A, Ayer S, Gnanavel N J Immunol. 2020; 204(4):879-891.
PMID: 31924647 PMC: 6994841. DOI: 10.4049/jimmunol.1900582.
Metabolism of amyloid β peptide and pathogenesis of Alzheimer's disease.
Saido T Proc Jpn Acad Ser B Phys Biol Sci. 2013; 89(7):321-39.
PMID: 23883611 PMC: 3758963. DOI: 10.2183/pjab.89.321.
Tachykinins and Neurokinin Receptors in Bone Marrow Functions: Neural-Hematopoietic Link.
Klassert T, Patel S, Rameshwar P J Receptor Ligand Channel Res. 2010; 2010(3):51-61.
PMID: 20593004 PMC: 2893333. DOI: 10.2147/jrlcr.s6509.